• Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to primary sidebar

Edda Technology

Leading Computer Assisted Radiology & Surgery Solutions

  • Home
  • About EDDA
    • Overview
    • Management Team
    • Careers
    • Press Releases
  • Products
    • IQQA®-BodyImaging Liver
    • IQQA®-BodyImaging Lung
    • IQQA®-BodyImaging Kidney
    • IQQA®-BodyImaging Interventional
    • IQQA®–Guide
    • IQQA®–Chest
    • IQQA®–Liver
    • IQQA®-Liver Function
    • IQQA®-eQMR
  • Events
  • Contact Us
  • Search
  • Home
  • About EDDA
    • Overview
    • Management Team
    • Careers
    • Press Releases
  • Products
    • IQQA®-BodyImaging Liver
    • IQQA®-BodyImaging Lung
    • IQQA®-BodyImaging Kidney
    • IQQA®-BodyImaging Interventional
    • IQQA®–Guide
    • IQQA®–Chest
    • IQQA®–Liver
    • IQQA®-Liver Function
    • IQQA®-eQMR
  • Events
  • Contact Us
  • Search
EDDA Technology 3D Imaging Software

EDDA Technology To Introduce the IQQA® Imaging-Guided Cancer Treatment Solution at Arab Health 2015

January 12, 2015 //  by Edda Technology

PRINCETON, NJ, January 12, 2015

EDDA Technology, a global leading provider in computer-assisted radiology and surgery solutions, announced that the company will be exhibiting at Arab Health 2015 in Dubai, United Arab Emirates. The company will showcase its award-winning IQQA® Platform and Product Suite, an innovative technology platform in imaging-guided cancer treatment.

The IQQA® Platform and Product Suite provides real-time, quantitative multimodality imaging solutions to support the entire patient management cycle, including early detection, treatment planning, intra-operative guidance and monitoring, and post-operative follow-up. IQQA® is currently being used by leading cancer centers worldwide, including King Faisal Specialist Hospital & Research Centre (KSA), Mayo Clinic (USA), Massachusetts General Hospital (USA), University of California San Francisco Medical Center (USA), University of Colorado Hospital (USA), as well as many other global luminary sites.

The company ‘s key highlight will be IQQA®-BodyImaging, which extends the proprietary fast and powerful 3D features  in the IQQA® product portfolio to thoracic, abdominal and pelvic scans. Features such as virtual knife for surgery and virtual needle for interventional planning, monitoring and follow-up, provide comprehensive tools for precision treatment delivery and quantifiable patient assessment.

“We are excited to bring to Arab Health our IQQA® Platform and Product Suite, an offering that covers close to 50% of the world’s cancer incidences and also addresses key challenges related to the treatment of prevalent lung and liver cancers in the region,” said Dr. Jianzhong Qian, president and CEO of EDDA Technology, and fellow of the American Institute of Medical and Biological Engineering (AIMBE). “We are confident that the IQQA® innovative solutions will aid in meeting and exceeding the clinical needs and treatment challenges in the Arab health market and abroad.”

As part of IQQA® Product Suite, the company will also be demonstrating IQQA®-Liver Multimodality and IQQA®-Chest. IQQA®-Liver Multimodality has been proven to offer significant time-saving and improved patient care for liver cancer treatment in more than 15,000 cases worldwide since 2009. IQQA®-Chest has been shown in a prospective study to assist physicians with early detection, by increasing physicians’ detection sensitivity of small lung nodules on X-ray from 63.8% to 92.7% (Academic Radiology Journal 2008;15:571-575).

EDDA will be exhibiting in Booth Z4E27 in the US Pavilion at Arab Health 2015.


IQQA® for thoracic, abdominal,and pelvic applications in cancer treatment planning, monitoring and follow-up.


About EDDA Technology

EDDA Technology, Inc. is an innovative clinical solution provider in the rapidly growing field of imaging-guided cancer treatment. By adopting a “fully quantitative, real-time interactive” approach to multimodality imaging analysis and guidance,  EDDA offers a series of next generation computer-assisted solutions to the entire patient management cycle, including enabling early detection and diagnosis, and enhancing efficiency and precision in treatment planning, guidance, monitoring, and follow-up. EDDA’s goal is to deliver, with broad accessibility, advanced imaging analytics technologies and services that improve clinical workflow and accuracy. EDDA is headquartered in Princeton, New Jersey, USA and has subsidiaries in China. IQQA® is a registered trademark of EDDA Technology. www.eddatech.com

Category: Press Release

Previous Post: « EDDA Technology Introduces the Newly FDA-Cleared IQQA® BodyImaging and Cloud-Based OnDemand Services for Imaging-Guided Cancer Treatment
Next Post: EDDA Technology Introduces the Newly FDA-Cleared IQQA®-Guide Intra-operative Precision 3D Navigation for Minimally Invasive and Robotic Surgical Treatment »

Primary Sidebar

Contact Us

609-919-9889
5 Independence Way, Princeton, NJ 08540

Request A Demo »

Explore Our Products

  • Overview
  • IQQA®-BodyImaging Liver
  • IQQA®-BodyImaging Lung
  • IQQA®-BodyImaging Kidney
  • IQQA®-BodyImaging Interventional
  • IQQA®-Guide
  • IQQA®-Chest
  • IQQA®-Liver
  • IQQA®-Liver Function
  • IQQA®-QMR

Resources

  • Talks & Publications
  • Press & Media 2011 – Present
  • Press & Media 2004 – 2010
  • Training & Tutorials for Existing Clients

Search this Website

EDDA-Technology-Logo
Frost & Sullivan Applauds EDDA's IQQA® Platform, an Advanced Imaging Analytics Technology that Improves Clinical Workflow and Accuracy

609-919-9889

5 Independence Way, Princeton, NJ 08540

Additional Resources

  • Talks & Publications
  • Press & Media 2011 – Present
  • Press & Media 2004 – 2010
  • Training & Tutorials for Existing Clients

Explore Our Products

  • liver-icon

    IQQA® BodyImaging Liver

  • lung-icon

    IQQA® BodyImaging Lung

  • kidney-icon

    IQQA® BodyImaging Kidney

Copyright © 2003 – 2023 EDDA Technology, Inc. All rights are reserved. | Site Map